Synta Pharmaceuticals, Inc. (NASDAQ: SNTA) CEO is back with his second insider buy in as many weeks. Today it ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE